NCCN publishes new recommendations for treating children with brain tumors

Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing

Nov. 6, 2023, was a bad day for Tom Curran, a charming scientist with a lilting Scottish brogue and the lifelong dream of curing childhood cancers.

April 11, 2025

Vol.51 No.14

By Claire Marie Porter

Clinical Roundup

Pediatric oncology programs lack sufficient psychosocial resources, Nemours Children’s Health study finds

Families facing a childhood cancer diagnosis experience a range of psychological, social, and emotional stressors, from anxiety to financial strain to sibling concerns.

April 11, 2025

Vol.51 No.14

In Brief

Michael Chan named chair of Wake Forest’s Department of Radiation Oncology

Michael Chan was appointed chair of Wake Forest University’s Department of Radiation Oncology, which he has led as interim chair since 2023. In his permanent role, he will advance the clinical, research and education missions of the department, while optimizing care delivery and clinical operations.

March 28, 2025

Vol.51 No.12

Clinical Roundup

UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma

Researchers at the University of Texas Health Science Center at San Antonio have discovered a way to delay or even block recurrence of the deadliest brain cancer after radiation.

March 28, 2025

Vol.51 No.12

Drugs & Targets

FDA approves cabozantinib for patients 12 and up with pNET and epNET

FDA approved cabozantinib (Cabometyx) for adult and pediatric patients 12 years of age and older with previously treated, unresectable, locally advanced or metastatic, well-differentiated pancreatic neuroendocrine tumors and well-differentiated extra-pancreatic neuroendocrine tumors.

March 28, 2025

Vol.51 No.12

In Brief

Nemours opens Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders

Nemours Children’s Health opened the Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders, on March 19. The institute is a state-of-the-art facility for pediatric patients in the Delaware Valley and beyond.

March 21, 2025

Vol.51 No.11

NCCN publishes new recommendations for treating children with brain tumors

YOU MAY BE INTERESTED IN

Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing

Pediatric oncology programs lack sufficient psychosocial resources, Nemours Children’s Health study finds

Michael Chan named chair of Wake Forest’s Department of Radiation Oncology

UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma

FDA approves cabozantinib for patients 12 and up with pNET and epNET

Nemours opens Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders

Renew today!

Subscriber content

NCCN publishes new recommendations for treating children with brain tumors

YOU MAY BE INTERESTED IN

Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s MercyWhistleblower lawsuit alleges wrongful firing

Pediatric oncology programs lack sufficient psychosocial resources, Nemours Children’s Health study finds

Michael Chan named chair of Wake Forest’s Department of Radiation Oncology

UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma

FDA approves cabozantinib for patients 12 and up with pNET and epNET

Nemours opens Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders

Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing